DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
98 hedge funds and large institutions have $901M invested in Dicerna Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
98
Holding in Top 10
5
Calls
$189K
Puts
–
Top Buyers
| 1 | +$10M | |
| 2 | +$8.17M | |
| 3 | +$6.41M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$4.96M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$3.99M |
Top Sellers
| 1 | -$25.2M | |
| 2 | -$19.8M | |
| 3 | -$9.49M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$6.56M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$4.5M |